CLINICAL RESEARCH: MYOCARDIAL INFARCTION
Genetic Polymorphisms of Platelet Glycoprotein Ia and the Risk for Premature Myocardial Infarction
Effects on the Release of sCD40L During the Acute Phase of Premature Myocardial Infarction
Charalambos Antoniades, MD,
Dimitris Tousoulis, MD, PhD, FACC*,
Carmen Vasiliadou, BSc, MSc,
Elli Stefanadi, MD,
Kyriakoula Marinou, MD and
Christodoulos Stefanadis, MD, FACC, FESC
Athens University Medical School, 1st Cardiology Department, Hippokration Hospital, Athens, Greece.
Manuscript received September 20, 2005;
revised manuscript received November 28, 2005,
accepted December 5, 2005.
* Reprint requests and correspondence: Dr. Dimitris Tousoulis, S Karagiorga 69, Glifada, Athens, Greece. (Email: tousouli{at}med.uoa.gr).
OBJECTIVES: The aim of this research was to evaluate the effect of genetic polymorphisms C807T and G1648A of platelet glycoprotein Ia (GPIa), on the risk for myocardial infarction (MI) and on the release of soluble CD40 ligand (sCD40L) during the acute phase of MI and one year after the event.
BACKGROUND: C807T and G1648A polymorphisms affect the density of GPIa on platelet surface, but their effect on the risk for MI and the release of sCD40L is unknown.
METHODS: The study population consisted of 219 patients with premature MI and 389 controls. One year after the event, 67 patients and 232 controls were recalled for the follow-up study.
RESULTS: The risk for MI in 807TT was 2.296 (95% confidence interval [CI]: 1.187 to 4.440) p < 0.05 versus CC + CT, 2.269 (95% CI: 1.085 to 4.745) p < 0.05 versus CC, and 2.135 (95% CI: 1.080 to 4.219) p < 0.05 versus CT. During the acute phase of MI, sCD40L was higher in 807CT + TT compared with 807CC (p < 0.01), an effect persisting after one year (p < 0.01). The carriage of 807T allele was an independent predictor for sCD40L during the acute phase of MI (ß = 9.442 [standard error (SE): 2.526], p = 0.001) and in the same patients one year later (ß = 8.282 [SE: 2.044], p = 0.001). In healthy individuals, 807T allele was associated with higher sCD40L levels compared with 807CC (p < 0.05), only among those with von Willebrand factor greater than or equal to median.
CONCLUSIONS: Genetic polymorphism C807T increases the risk for premature MI. 807T allele is an independent predictor for sCD40L levels during the acute phase of premature MI as well as one year after the event, while it is associated with elevated sCD40L levels in healthy subjects, only in the presence of high von Willebrand levels.
|
Abbreviations and Acronyms
| | CABG = coronary artery bypass grafting | | CI = confidence interval | | GPIa = glycoprotein Ia | | GPVI = glycoprotein VI | | HDL = high-density lipoprotein | | MI = myocardial infarction | | PCI = percutaneous coronary intervention | | sCD40L = soluble CD40 ligand | | STEMI = ST-segment elevated myocardial infarction | | vWF = von Willebrand factor |
|
This article has been cited by other articles:
|
|
|
|
 
C. Antoniades, C. Bakogiannis, D. Tousoulis, A. S. Antonopoulos, and C. Stefanadis
The CD40/CD40 ligand system: linking inflammation with atherothrombosis.
J. Am. Coll. Cardiol.,
August 18, 2009;
54(8):
669 - 677.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. CHIRAS, E. D. PAPADAKIS, A. KATOPODI, E. CHATZIANESTI, K. FOURTOUNAS, S. PAPAKONSTANTINOU, I. THEODOROPOULOS, A. DAKOURAS, N. ZEREFOS, D. VALIS, et al.
Platelet GP IIIA Polymorphism HPA-1 (PLA1/2) Is Associated with Hypertension as the Primary Cause for End-stage Renal Disease in Hemodialysis Patients from Greece
In Vivo,
January 1, 2009;
23(1):
177 - 181.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. A. Iakoubova, C. H. Tong, C. M. Rowland, T. G. Kirchgessner, B. A. Young, A. R. Arellano, D. Shiffman, M. S. Sabatine, H. Campos, C. J. Packard, et al.
Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials.
J. Am. Coll. Cardiol.,
January 29, 2008;
51(4):
435 - 443.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
